Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Grows By 1,188.9%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 11,600 shares, an increase of 1,188.9% from the December 15th total of 900 shares. Based on an average daily volume of 37,600 shares, the short-interest ratio is presently 0.3 days.

NLS Pharmaceutics Price Performance

Shares of NLSPW traded down $0.00 during midday trading on Monday, hitting $0.01. The company had a trading volume of 43,948 shares, compared to its average volume of 58,978. The company’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.02. NLS Pharmaceutics has a 52 week low of $0.01 and a 52 week high of $0.10.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).